{
  "ptid_time": "032_S_6294_2018-05-03",
  "img_path": "/data/qiuhui/data/adni/images/032_S_6294/2018-05-03/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 83,615 mm³, 77.8% above the reference mean. With a Z-score of 2.26 (98.8th percentile), this represents significant enlargement; hippocampal volume measures 7,218 mm³, 3.6% above the reference mean. With a Z-score of 0.31 (62.2th percentile), this represents normal volume ; whole brain volume measures 1,084,460 mm³, 5.4% above the reference mean. With a Z-score of 0.70 (75.9th percentile), this represents normal volume ; entorhinal cortex volume measures 4,828 mm³, 21.6% above the reference mean. With a Z-score of 1.42 (92.2th percentile), this represents mild enlargement; fusiform gyrus volume measures 22,631 mm³, 25.3% above the reference mean. With a Z-score of 2.19 (98.6th percentile), this represents significant enlargement; middle temporal gyrus volume measures 25,241 mm³, 25.1% above the reference mean. With a Z-score of 2.25 (98.8th percentile), this represents significant enlargement. ",
  "text_data": "Age is 82.4 years. Gender is Male. Education: 16 years. MMSE: 28.0. MoCA: 25.0. Logical Memory: 20.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.70 SUVR (profound elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The ventricular volume is significantly enlarged (Z-score 2.26), which is often seen in neurodegenerative conditions like Alzheimer’s disease (AD). However, hippocampal volume is normal, and other regions (entorhinal cortex, fusiform gyrus, middle temporal gyrus) show enlargement rather than atrophy, which is atypical for AD. The MMSE (28) and MoCA (25) scores are within normal limits, and the absence of APOE4 reduces genetic risk. The profoundly elevated AV45 (amyloid PET) suggests amyloid pathology, but the structural findings do not align with typical AD progression.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given amyloid positivity but preserved cognitive scores and atypical structural changes)  \n**Confidence:** **Medium** (due to conflicting imaging findings—ventricular enlargement and amyloid positivity vs. normal cognition and atypical regional enlargement)",
  "timestamp": "2025-07-26T05:09:02.907148"
}